Micheal Burry’s Massive Bets Against Palantir and Oracle Highlight Two Prominent AI Failure Modalities

Published November 16, 2026, 8:45am ET · 2 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A stylized, dot-matrix portrait of a man in profile, facing right. His face and hair are rendered in light-colored dots, creating a pixelated effect against a dark, solid background. He wears a collared shirt visible under a darker jacket, with the details also formed by varying dots. The overall impression is a graphic, halftone representation of a thoughtful individual.
The thoughtful profile of an investor, reflecting the strategic thinking behind Michael Burry's significant put positions against tech giants like Palantir and Oracle. © 24/7 Wall St.

Palantir (NASDAQ:PLTR | PLTR Price Prediction) and Oracle (NYSE:ORCL) both beat estimates in their latest reports, and Michael Burry holds put positions in both. Palantir is the valuation risk: almost no debt, but priced as if it can’t slip up. Oracle is the balance-sheet risk, with a datacenter expansion that burns cash. Their market caps sit close together, at ~$387.5B and ~$390.9B.

Palantir Sells Workflows While Oracle Sells Megawatts

Palantir’s Q3 revenue rose 95.9% to $2.31B[1]. U.S. commercial revenue reached $984M, up 148%[1], and passed U.S. government sales for the first time. That shift matters because companies buy faster than the government does. Pilots turn into contracts quickly: one industrial materials customer went from a nearly $3 million[2] trial to a $29 million ACV deal. CEO Alex Karp put it this way: “Once you go Palantir, you don’t go back.”[2]

Oracle’s quarter ran on hardware. Cloud infrastructure revenue rose 121% to $7.39B[3], while software license revenue fell 15%. GPU rentals are taking over from the old licensing business. GPU use hit 97.9%[4], so demand looks real.

Business Driver Palantir Oracle
Growth Engine AIP and Ontology deployments AI training and inference capacity
Adjusted EPS $0.44[1] $1.92[3]
Quarterly Capex ~$8M $28.50B[3]
Free Cash Flow $1.216B adjusted[2] Negative $5.40B[3]
PLTR earnings explorer

One Risk Lives in the Multiple, the Other in the Balance Sheet

Palantir’s weak spot is its price. At 238 times earnings with a 0.54% free cash flow yield, the stock assumes hypergrowth keeps going. There are cracks. Total contract value grew just 6%[1]. Stock-based pay rose to $318.9M from $172.3M[1]. Receivables reached $1.88B from $1.04B[1]. Management says its shorter Sovereign AI contracts will get larger later. Maybe.

Oracle’s weak spot is funding. Capex jumped 235.2%[3], total liabilities rose to $236.06B, and interest expense increased 55% to $1.4B. Co-CEO Clay Magouyrk said new contracts require no extra cash: “We said it does not require additional cash from Oracle.”[4] Even so, Oracle gave no timeline for getting back to positive free cash flow.

Contract Conversion Will Decide Who Breaks First

I will be watching whether Palantir’s contracts get longer as it works toward Q4 revenue guidance of $2.649B to $2.653B[1]. For Oracle, watch the $664B[3] backlog of signed contracts. Management expects around half[4] of it to turn into revenue within 36 months.

Why I Prefer Palantir’s Problem Over Oracle’s

Over six months, Palantir rose 25.38% while Oracle fell 34.57%. I find Palantir’s risk easier to live with. Its valuation can shrink, but a company with $1.20B[1] in quarterly operating cash flow and almost no debt can absorb that. Oracle’s risk builds on itself: if AI customers slip up, the debt is still there.

I’d want Palantir’s contract bookings to speed up before I trust its multiple. Oracle’s $0.50 quarterly dividend may draw income investors, but I’d wait for a free cash flow timeline. If that timeline comes, my view changes.

Contact [email protected] for any questions or corrections.

Alex Sirois

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

All articles →

Sources

  1. Palantir Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  2. Palantir Technologies Inc. Q3 2026 earnings callPalantir Technologies Inc.
  3. Oracle Form 8-K (Q1 FY2027)U.S. Securities and Exchange Commission
  4. Oracle Corporation Q1 2027 earnings callOracle Corporation